Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

New Leaf Venture Associates II, L.P. — Versartis, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / New Leaf Venture Associates II, L.P.

New Leaf Venture Associates II, L.P.

10% owner at WORLD HEART CORP · on record since Aug 8, 2008
Director at Oxford Immunotec Global PLC · on record since Nov 21, 2013
10% owner at Oxford Immunotec Global PLC · on record since Nov 21, 2013
Member of 10% owner group at ICAGEN INC · on record since Jul 29, 2011
10% owner at Durata Therapeutics, Inc. · on record since Jul 26, 2012
10% owner at MARSHALL EDWARDS INC · on record since Dec 28, 2012
10% owner at iRhythm Holdings, Inc. · on record since Oct 25, 2016
Director at Versartis, Inc. · on record since Mar 28, 2014
10% owner at Versartis, Inc. · on record since Mar 28, 2014
10% owner at Comtrix, Inc. · on record since Mar 20, 2014
10% owner at Neuronetics, Inc. · on record since Jun 27, 2018
10% owner at Principia Biopharma Inc. · on record since Sep 20, 2018

Insider trading activity of New Leaf Venture Associates II, L.P.

Transactions on record: 1; since Nov 13, 2014

Open-market buys: 0

Open-market sells: 1; $15.5M

Companies traded: 1; last filing Nov 13, 2014

Figures computed from official regulatory filings — methodology.

Companies where New Leaf Venture Associates II, L.P. has traded

Versartis, Inc.1 tx · $15.5M · Nov 13, 2014

Track record of New Leaf Venture Associates II, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of New Leaf Venture Associates II, L.P.

Co-insiders of New Leaf Venture Associates II, L.P.

New Leaf Venture Management II, L.L.C.Comtrix, Inc. +9
New Leaf Ventures II, L.P.Comtrix, Inc. +9
HUNT RONALDComtrix, Inc. +8
CHAMBON PHILIPPEComtrix, Inc. +7
Delagardelle JeaniComtrix, Inc. +7
Lathi Vijay KComtrix, Inc. +7
NIEDEL JAMESComtrix, Inc. +6

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

AKKARAJU SRINIVASDurata Therapeutics, Inc. +5

Ratcliffe LiamComtrix, Inc. +5

HEALY JAMESDurata Therapeutics, Inc. +2

POWELL MICHAELDurata Therapeutics, Inc. +2

AISLING CAPITAL III LPDurata Therapeutics, Inc. +1

Aisling Capital Partners III LLCDurata Therapeutics, Inc. +1

Aisling Capital Partners III LPDurata Therapeutics, Inc. +1

Becker Steven RICAGEN INC +1

BIOTECHNOLOGY VALUE FUND II LPICAGEN INC +1

BIOTECHNOLOGY VALUE FUND L PICAGEN INC +1

BVF INC/ILICAGEN INC +1

BVF PARTNERS L P/ILICAGEN INC +1

ELMS STEVEDurata Therapeutics, Inc. +1

LAMPERT MARK NICAGEN INC +1

Machado Clarence PatrickComtrix, Inc. +1

Mehra AnandPrincipia Biopharma Inc. +1

OBOYLE KEVIN CDurata Therapeutics, Inc. +1

Purcell Dennis JDurata Therapeutics, Inc. +1

SCHIFF ANDREW NDurata Therapeutics, Inc. +1

SMITH G STACYICAGEN INC +1

Sofinnova Management VIII, L.L.C.Principia Biopharma Inc. +1

Sofinnova Venture Partners VIII, L.P.Principia Biopharma Inc. +1

SRB Management, L.P.ICAGEN INC +1

WALKER PATRICK PICAGEN INC +1

WALKER REID SICAGEN INC +1

WALKER SMITH CAPITAL L PICAGEN INC +1

Walker Smith Capital QP L PICAGEN INC +1

WALKER SMITH INTERNATIONAL FUND LTDICAGEN INC +1

WS CAPITAL LLCICAGEN INC +1

WS CAPITAL MANAGEMENT LPICAGEN INC +1

WS OPPORTUNITY FUND INTERNATIONAL LTDICAGEN INC +1

WS Opportunity Fund L PICAGEN INC +1

WS Opportunity Fund QP L PICAGEN INC +1

WS VENTURES MANAGEMENT L PICAGEN INC +1

WSV MANAGEMENT L L CICAGEN INC +1

ABBOTT LABORATORIESICAGEN INC

ABIOMED INCWORLD HEART CORP

Admiralty Advisors LLCMARSHALL EDWARDS INC

Advent Life Sciences Fund I LPVersartis, Inc.

Advent Life Sciences LLPVersartis, Inc.

Ahrens Brenton KarlDurata Therapeutics, Inc.

Alimentaria International, Inc.ICAGEN INC

Allen NealComtrix, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Versartis, Inc.	Nov 13, 2014	Sell	-800,000	19.37 USD	$15.5M	SEC